We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Woodcock Grilled by Senators Over FDA Lag in Implementing Biosimilars
Woodcock Grilled by Senators Over FDA Lag in Implementing Biosimilars
CDER Director Janet Woodcock came under fire Sept. 17 from senators demanding to know why the FDA is years behind Europe and Canada in establishing a workable program for biosimilars.